Meda of Sweden is to acquire the US speciality pharma company Alaven Pharmaceutical to enhance its US marketing capabilities and expand its therapeutic focus to include both gastroenterology and women's health, areas it already operates in outside ...
After months of speculation Sanofi-Aventis, the French pharma major, at the weekend unveiled an all-cash $69.00 a share bid for Genzyme, which values the US biotech at about $18.5 billion. Not surprisingly, the Genzyme board unanimously rejected the ...
A federal judge has denied Sanofi-Aventis 's request for a preliminary injunction that would have directed the US FDA to suspend and withdraw its approval of a generic version of Lovenox (enoxaparin sodium) from Sandoz (Novartis) and partner Momenta ...
Daiichi Sankyo has raised its sales and profit guidance for the first half of the current fiscal year on expectations of a better than expected performance from its Ranbaxy generics subsidiary.
The Japanese firm is now forecasting a consolidated net ...
The research-based drug industry association Medicines Australia has written to a senate committee urging that the Parliament should pass before 1 October a medicines pricing bill that aims to save taxpayers Aus$1.9 billion (US$1.7 billion) over a ...
